Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124084152 | 12408415 | 2 | F | 20130203 | 20160824 | 20160526 | 20160902 | EXP | DK-BAXTER-2016BAX026693 | BAXTER | 69.50 | YR | M | Y | 0.00000 | 20160902 | LW | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124084152 | 12408415 | 1 | PS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 12142 | 1500 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 2 | SS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 12142 | 1500 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 3 | SS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 12142 | 1500 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 4 | SS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 12142 | 1500 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 5 | SS | SENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 12142 | 1500 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 6 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 100 | MG | |||||||
| 124084152 | 12408415 | 7 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 100 | MG | |||||||
| 124084152 | 12408415 | 8 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 100 | MG | |||||||
| 124084152 | 12408415 | 9 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 100 | MG | |||||||
| 124084152 | 12408415 | 10 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 100 | MG | |||||||
| 124084152 | 12408415 | 11 | SS | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 2 | MG | SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 12 | SS | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 2 | MG | SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 13 | SS | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 2 | MG | SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 14 | SS | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 2 | MG | SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 15 | SS | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | R-CHOP CHEMOTHERAPY | U | 0 | 2 | MG | SOLUTION FOR INJECTION | ||||||
| 124084152 | 12408415 | 16 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | 800 | MG | ||||||||
| 124084152 | 12408415 | 17 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | 800 | MG | ||||||||
| 124084152 | 12408415 | 18 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | 800 | MG | ||||||||
| 124084152 | 12408415 | 19 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | 800 | MG | ||||||||
| 124084152 | 12408415 | 20 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | 800 | MG | ||||||||
| 124084152 | 12408415 | 21 | C | VICTOZA | LIRAGLUTIDE | 1 | Unknown | 0 | 1 | DF | |||||||||
| 124084152 | 12408415 | 22 | C | Diclon | DICLOFENAC SODIUM | 1 | Unknown | 0 | 100 | MG | QD | ||||||||
| 124084152 | 12408415 | 23 | C | Pinex | ACETAMINOPHEN | 1 | Unknown | 500 MGX6 | 0 | 3000 | MG | ||||||||
| 124084152 | 12408415 | 24 | C | hjertemagnyl | ASPIRINMAGNESIUM OXIDE | 1 | Unknown | 0 | 75 | MG | QD | ||||||||
| 124084152 | 12408415 | 25 | C | aciclovir | ACYCLOVIR | 1 | Unknown | 0 | |||||||||||
| 124084152 | 12408415 | 26 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 0 | 20 | MG | QD | ||||||||
| 124084152 | 12408415 | 27 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Unknown | 0 | 3 | MG | QD | ||||||||
| 124084152 | 12408415 | 28 | C | codeine | CODEINE | 1 | Unknown | 0 | 25 | MG | QID | ||||||||
| 124084152 | 12408415 | 29 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | 0 | 400 | MG | TID | ||||||||
| 124084152 | 12408415 | 30 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Unknown | 0 | 75 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124084152 | 12408415 | 1 | B-cell lymphoma |
| 124084152 | 12408415 | 6 | B-cell lymphoma |
| 124084152 | 12408415 | 11 | B-cell lymphoma |
| 124084152 | 12408415 | 16 | B-cell lymphoma |
| 124084152 | 12408415 | 21 | Product used for unknown indication |
| 124084152 | 12408415 | 22 | Product used for unknown indication |
| 124084152 | 12408415 | 23 | Product used for unknown indication |
| 124084152 | 12408415 | 24 | Product used for unknown indication |
| 124084152 | 12408415 | 25 | Product used for unknown indication |
| 124084152 | 12408415 | 26 | Product used for unknown indication |
| 124084152 | 12408415 | 27 | Product used for unknown indication |
| 124084152 | 12408415 | 28 | Product used for unknown indication |
| 124084152 | 12408415 | 29 | Product used for unknown indication |
| 124084152 | 12408415 | 30 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124084152 | 12408415 | DE |
| 124084152 | 12408415 | HO |
| 124084152 | 12408415 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124084152 | 12408415 | Ascites | |
| 124084152 | 12408415 | Asthenia | |
| 124084152 | 12408415 | Cardiac failure | |
| 124084152 | 12408415 | Cardiomegaly | |
| 124084152 | 12408415 | Hallucination | |
| 124084152 | 12408415 | Malignant peritoneal neoplasm | |
| 124084152 | 12408415 | Pleural effusion | |
| 124084152 | 12408415 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124084152 | 12408415 | 1 | 20121012 | 0 | ||
| 124084152 | 12408415 | 2 | 20121102 | 0 | ||
| 124084152 | 12408415 | 3 | 20121123 | 0 | ||
| 124084152 | 12408415 | 4 | 20121214 | 0 | ||
| 124084152 | 12408415 | 5 | 20130104 | 20130125 | 0 | |
| 124084152 | 12408415 | 6 | 20121012 | 0 | ||
| 124084152 | 12408415 | 7 | 20121102 | 0 | ||
| 124084152 | 12408415 | 8 | 20121123 | 0 | ||
| 124084152 | 12408415 | 9 | 20121214 | 0 | ||
| 124084152 | 12408415 | 10 | 20130104 | 20130125 | 0 | |
| 124084152 | 12408415 | 11 | 20121012 | 0 | ||
| 124084152 | 12408415 | 12 | 20121102 | 0 | ||
| 124084152 | 12408415 | 13 | 20121123 | 0 | ||
| 124084152 | 12408415 | 14 | 20121214 | 0 | ||
| 124084152 | 12408415 | 15 | 20130104 | 20130125 | 0 | |
| 124084152 | 12408415 | 16 | 20121012 | 0 | ||
| 124084152 | 12408415 | 17 | 20121102 | 0 | ||
| 124084152 | 12408415 | 18 | 20121123 | 0 | ||
| 124084152 | 12408415 | 19 | 20121214 | 0 | ||
| 124084152 | 12408415 | 20 | 20130104 | 20130429 | 0 |